End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
116,600 KRW | +3.64% | +9.38% | +50.84% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Samcheondang Pharmaceutical
67.9
%
| 127,809 | 72.1 % | 130,912 | 67.9 % | +2.43% |
Optus Pharmaceutical
32.1
%
| 49,526 | 27.9 % | 61,756 | 32.1 % | +24.69% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
95.1
%
| 166,840 | 94.1 % | 183,179 | 95.1 % | +9.79% |
Overseas
4.9
%
| 10,496 | 5.9 % | 9,490 | 4.9 % | -9.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
In-Seok Jeon
CEO | Chief Executive Officer | 50 | - |
Dae-In Yoon
CHM | Chairman | 74 | - |
Sae-Young Chun
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Hyung-Jin Yoon
BRD | Director/Board Member | 51 | - |
Sang-Ho Shim
BRD | Director/Board Member | 55 | - |
Young-Gil Yoo
SAM | Sales & Marketing | 56 | - |
Jung-Hwan Cho
AUD | Comptroller/Controller/Auditor | 69 | - |
Hyeong-Gyun Jeon
PRN | Corporate Officer/Principal | 63 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dae-In Yoon
CHM | Chairman | 74 | - |
In-Seok Jeon
CEO | Chief Executive Officer | 50 | - |
Yong-Gwan Kim
BRD | Director/Board Member | 59 | - |
Sang-Ho Shim
BRD | Director/Board Member | 55 | - |
Hyung-Jin Yoon
BRD | Director/Board Member | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,457,472 | 13,935,577 ( 59.41 %) | 700,000 ( 2.984 %) | 59.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
700,000 | 2.98% | 73,106,775 $ | |
6,357,733 | 39.36% | 33,199,510 $ |
Company contact information
SAM CHUN DANG PHARM Co., Ltd.
71 Jeyakgongdan 2-gil Hyangnam-eup
18622, Hwaseong-si
+
http://www.scd.co.krSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+50.84% | 1.96B | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- A000250 Stock
- Company Sam Chun Dang Pharm. Co., Ltd